{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:42:58Z","timestamp":1784569378463,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010447","name":"DZHK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The cation channel transient receptor potential melastatin 4 (TRPM4) is a calcium-activated non-selective cation channel and acts in cardiomyocytes as a negative modulator of the L-type Ca<jats:sup>2+<\/jats:sup> influx. Global deletion of TRPM4 in the mouse led to increased cardiac contractility under \u03b2-adrenergic stimulation. Consequently, cardiomyocyte-specific inactivation of the TRPM4 function appears to be a promising strategy to improve cardiac contractility in heart failure patients. The aim of this study was to develop a gene therapy approach in mice that specifically silences the expression of TRPM4 in cardiomyocytes. First, short hairpin RNA<jats:sup>miR30<\/jats:sup> (shRNA<jats:sup>miR30<\/jats:sup>) sequences against the TRPM4 mRNA were screened in vitro using lentiviral transduction for a stable expression of the shRNA cassettes. Western blot analysis identified three efficient shRNA<jats:sup>miR30<\/jats:sup> sequences out of six, which reduced the endogenous TRPM4 protein level by up to 90 \u00b1 6%. Subsequently, the most efficient shRNA<jats:sup>miR30<\/jats:sup> sequences were delivered into cardiomyocytes of adult mice using adeno-associated virus serotype 9 (AAV9)-mediated gene transfer. Initially, the AAV9 vector particles were administered via the lateral tail vein, which resulted in a downregulation of TRPM4 by 46 \u00b1 2%. Next, various optimization steps were carried out to improve knockdown efficiency in vivo. First, the design of the expression cassette was streamlined for integration in a self-complementary AAV vector backbone for a faster expression. Compared to the application via the lateral tail vein, intravenous application via the retro-orbital sinus has the advantage that the vector solution reaches the heart directly and in a high concentration, and eventually a TRPM4 knockdown efficiency of 90 \u00b1 7% in the heart was accomplished by this approach. By optimization of the shRNA<jats:sup>miR30<\/jats:sup> constructs and expression cassette as well as the route of AAV9 vector application, a 90% reduction of TRPM4 expression was achieved in the adult mouse heart. In the future, AAV9-RNAi-mediated inactivation of TRPM4 could be a promising strategy to increase cardiac contractility in preclinical animal models of acute and chronic forms of cardiac contractile failure.<\/jats:p>","DOI":"10.1007\/s00424-021-02521-6","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T08:49:17Z","timestamp":1613292557000},"page":"533-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of an AAV9-RNAi-mediated silencing strategy to abrogate TRPM4 expression in the adult heart"],"prefix":"10.1007","volume":"473","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-3732","authenticated-orcid":false,"given":"Rebekka","family":"Medert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jungmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Flockerzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Most","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Freichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"2521_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Plante-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379:11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1716153","journal-title":"N Engl J Med"},{"key":"2521_CR2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/ni.1648","volume":"9","author":"G Barbet","year":"2008","unstructured":"Barbet G, Demion M, Moura IC, Serafini N, Leger T, Vrtovsnik F, Monteiro RC, Guinamard R, Kinet JP, Launay P (2008) The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nat Immunol 9:1148\u20131156. https:\/\/doi.org\/10.1038\/ni.1648","journal-title":"Nat Immunol"},{"key":"2521_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1089\/hum.2008.123","volume":"19","author":"LT Bish","year":"2008","unstructured":"Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao G, Wilson JM, Sweeney HL (2008) Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther 19:1359\u20131368. https:\/\/doi.org\/10.1089\/hum.2008.123","journal-title":"Hum Gene Ther"},{"key":"2521_CR4","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ymthe.2020.02.009","volume":"28","author":"K Borner","year":"2020","unstructured":"Borner K, Kienle E, Huang LY, Weinmann J, Sacher A, Bayer P, Stullein C, Fakhiri J, Zimmermann L, Westhaus A, Beneke J, Beil N, Wiedtke E, Schmelas C, Miltner D, Rau A, Erfle H, Krausslich HG, Muller M, Agbandje-McKenna M, Grimm D (2020) Pre-arrayed Pan-AAV peptide display libraries for rapid single-round screening. Mol Ther 28:1016\u20131032. https:\/\/doi.org\/10.1016\/j.ymthe.2020.02.009","journal-title":"Mol Ther"},{"key":"2521_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/mt.2008.231","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, Martins I, Davidson BL (2009) Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther 17:169\u2013175. https:\/\/doi.org\/10.1038\/mt.2008.231","journal-title":"Mol Ther"},{"key":"2521_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/gt.2010.141","volume":"18","author":"A Geisler","year":"2011","unstructured":"Geisler A, Jungmann A, Kurreck J, Poller W, Katus HA, Vetter R, Fechner H, Muller OJ (2011) microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther 18:199\u2013209. https:\/\/doi.org\/10.1038\/gt.2010.141","journal-title":"Gene Ther"},{"key":"2521_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.tcm.2016.11.001","volume":"27","author":"B Greenberg","year":"2017","unstructured":"Greenberg B (2017) Gene therapy for heart failure. Trends Cardiovasc Med 27:216\u2013222. https:\/\/doi.org\/10.1016\/j.tcm.2016.11.001","journal-title":"Trends Cardiovasc Med"},{"key":"2521_CR8","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/nprot.2006.207","volume":"1","author":"JC Grieger","year":"2006","unstructured":"Grieger JC, Choi VW, Samulski RJ (2006) Production and characterization of adeno-associated viral vectors. Nat Protoc 1:1412\u20131428. https:\/\/doi.org\/10.1038\/nprot.2006.207","journal-title":"Nat Protoc"},{"key":"2521_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1758-907X-2-8","volume":"2","author":"D Grimm","year":"2011","unstructured":"Grimm D (2011) The dose can make the poison: lessons learned from adverse in vivo toxicities caused by RNAi overexpression. Silence 2:8. https:\/\/doi.org\/10.1186\/1758-907X-2-8","journal-title":"Silence"},{"key":"2521_CR10","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1172\/JCI34129","volume":"117","author":"D Grimm","year":"2007","unstructured":"Grimm D, Kay MA (2007) Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest 117:3633\u20133641. https:\/\/doi.org\/10.1172\/JCI34129","journal-title":"J Clin Invest"},{"key":"2521_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA (2006) Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 441:537\u2013541. https:\/\/doi.org\/10.1038\/nature04791","journal-title":"Nature"},{"key":"2521_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtm.2019.11.020","volume":"17","author":"SO Han","year":"2020","unstructured":"Han SO, Li S, McCall A, Arnson B, Everitt JI, Zhang H, Young SP, ElMallah MK, Koeberl DD (2020) Comparisons of infant and adult mice reveal age effects for liver depot gene therapy in Pompe disease. Mol Ther Methods Clin Dev 17:133\u2013142. https:\/\/doi.org\/10.1016\/j.omtm.2019.11.020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2521_CR13","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.119.044431","volume":"141","author":"GK Hovingh","year":"2020","unstructured":"Hovingh GK, Lepor NE, Kallend D, Stoekenbroek RM, Wijngaard PLJ, Raal FJ (2020) Inclisiran durably lowers low-density lipoprotein cholesterol and proprotein convertase subtilisin\/kexin type 9 expression in homozygous familial hypercholesterolemia: the ORION-2 Pilot Study. Circulation 141:1829\u20131831. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044431","journal-title":"Circulation"},{"key":"2521_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","volume":"14","author":"K Inagaki","year":"2006","unstructured":"Inagaki K, Fuess S, Storm TA, Gibson GA, McTiernan CF, Kay MA, Nakai H (2006) Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther 14:45\u201353. https:\/\/doi.org\/10.1016\/j.ymthe.2006.03.014","journal-title":"Mol Ther"},{"key":"2521_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cvr\/cvv009","volume":"105","author":"G Jacobs","year":"2015","unstructured":"Jacobs G, Oosterlinck W, Dresselaers T, Geenens R, Kerselaers S, Himmelreich U, Herijgers P, Vennekens R (2015) Enhanced beta-adrenergic cardiac reserve in Trpm4(-)\/(-) mice with ischaemic heart failure. Cardiovasc Res 105:330\u2013339. https:\/\/doi.org\/10.1093\/cvr\/cvv009","journal-title":"Cardiovasc Res"},{"key":"2521_CR16","doi-asserted-by":"publisher","unstructured":"Jungmann A, Leuchs B, Katus HA, Rommelaere J, Muller OJ (2017) Protocol for efficient generation and characterization of adeno-associated viral (AAV) vectors. Hum Gene Ther Methods. https:\/\/doi.org\/10.1089\/hum.2017.192","DOI":"10.1089\/hum.2017.192"},{"key":"2521_CR17","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1172\/JCI38292","volume":"119","author":"M Kruse","year":"2009","unstructured":"Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, Ohmert I, Schulze-Bahr E, Brink P, Pongs O (2009) Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 119:2737\u20132744. https:\/\/doi.org\/10.1172\/JCI38292","journal-title":"J Clin Invest"},{"key":"2521_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0092-8674(02)00719-5","volume":"109","author":"P Launay","year":"2002","unstructured":"Launay P, Fleig A, Perraud AL, Scharenberg AM, Penner R, Kinet JP (2002) TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization. Cell 109:397\u2013407. https:\/\/doi.org\/10.1016\/s0092-8674(02)00719-5","journal-title":"Cell"},{"key":"2521_CR19","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1098845","volume":"306","author":"P Launay","year":"2004","unstructured":"Launay P, Cheng H, Srivatsan S, Penner R, Fleig A, Kinet JP (2004) TRPM4 regulates calcium oscillations after T cell activation. Science 306:1374\u20131377. https:\/\/doi.org\/10.1126\/science.1098845","journal-title":"Science"},{"key":"2521_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1161\/CIRCGENETICS.109.930867","volume":"3","author":"H Liu","year":"2010","unstructured":"Liu H, El Zein L, Kruse M, Guinamard R, Beckmann A, Bozio A, Kurtbay G, Megarbane A, Ohmert I, Blaysat G, Villain E, Pongs O, Bouvagnet P (2010) Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease. Circ Cardiovasc Genet 3:374\u2013385. https:\/\/doi.org\/10.1161\/CIRCGENETICS.109.930867","journal-title":"Circ Cardiovasc Genet"},{"key":"2521_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E, Bhattacharyya S, Shelton JM, Bassel-Duby R, Olson EN (2016) Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351:400\u2013403. https:\/\/doi.org\/10.1126\/science.aad5725","journal-title":"Science"},{"key":"2521_CR22","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1172\/JCI41348","volume":"120","author":"I Mathar","year":"2010","unstructured":"Mathar I, Vennekens R, Meissner M, Kees F, Van der Mieren G, Camacho Londono JE, Uhl S, Voets T, Hummel B, van den Bergh A, Herijgers P, Nilius B, Flockerzi V, Schweda F, Freichel M (2010) Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J Clin Invest 120:3267\u20133279. https:\/\/doi.org\/10.1172\/JCI41348","journal-title":"J Clin Invest"},{"key":"2521_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/CIRCRESAHA.114.302835","volume":"114","author":"I Mathar","year":"2014","unstructured":"Mathar I, Kecskes M, Van der Mieren G, Jacobs G, Camacho Londono JE, Uhl S, Flockerzi V, Voets T, Freichel M, Nilius B, Herijgers P, Vennekens R (2014) Increased beta-adrenergic inotropy in ventricular myocardium from Trpm4-\/- mice. Circ Res 114:283\u2013294. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302835","journal-title":"Circ Res"},{"key":"2521_CR24","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1073\/pnas.0801775105","volume":"105","author":"JL McBride","year":"2008","unstructured":"McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL (2008) Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A 105:5868\u20135873. https:\/\/doi.org\/10.1073\/pnas.0801775105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2521_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"DM McCarty","year":"2001","unstructured":"McCarty DM, Monahan PE, Samulski RJ (2001) Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 8:1248\u20131254. https:\/\/doi.org\/10.1038\/sj.gt.3301514","journal-title":"Gene Ther"},{"key":"2521_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00395-020-00831-x","volume":"115","author":"R Medert","year":"2020","unstructured":"Medert R, Pironet A, Bacmeister L, Segin S, Londono JEC, Vennekens R, Freichel M (2020) Genetic background influences expression and function of the cation channel TRPM4 in the mouse heart. Basic Res Cardiol 115:70. https:\/\/doi.org\/10.1007\/s00395-020-00831-x","journal-title":"Basic Res Cardiol"},{"key":"2521_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cardiores.2005.12.017","volume":"70","author":"OJ Muller","year":"2006","unstructured":"Muller OJ, Leuchs B, Pleger ST, Grimm D, Franz WM, Katus HA, Kleinschmidt JA (2006) Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovasc Res 70:70\u201378. https:\/\/doi.org\/10.1016\/j.cardiores.2005.12.017","journal-title":"Cardiovasc Res"},{"key":"2521_CR28","doi-asserted-by":"publisher","first-page":"6638","DOI":"10.1038\/s41598-018-25001-x","volume":"8","author":"A Nakagaki","year":"2018","unstructured":"Nakagaki A, Urakawa A, Hirano S, Anami T, Kishino T (2018) Application of droplet digital PCR in the analysis of genome integration and organization of the transgene in BAC transgenic mice. Sci Rep 8:6638. https:\/\/doi.org\/10.1038\/s41598-018-25001-x","journal-title":"Sci Rep"},{"key":"2521_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.mce.2011.01.007","volume":"335","author":"PL Nelson","year":"2011","unstructured":"Nelson PL, Zolochevska O, Figueiredo ML, Soliman A, Hsu WH, Feng JM, Zhang H, Cheng H (2011) Regulation of Ca(2+)-entry in pancreatic alpha-cell line by transient receptor potential melastatin 4 plays a vital role in glucagon release. Mol Cell Endocrinol 335:126\u2013134. https:\/\/doi.org\/10.1016\/j.mce.2011.01.007","journal-title":"Mol Cell Endocrinol"},{"key":"2521_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/stem.1264","volume":"31","author":"P Nelson","year":"2013","unstructured":"Nelson P, Ngoc Tran TD, Zhang H, Zolochevska O, Figueiredo M, Feng JM, Gutierrez DL, Xiao R, Yao S, Penn A, Yang LJ, Cheng H (2013) Transient receptor potential melastatin 4 channel controls calcium signals and dental follicle stem cell differentiation. Stem Cells 31:167\u2013177. https:\/\/doi.org\/10.1002\/stem.1264","journal-title":"Stem Cells"},{"key":"2521_CR31","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","volume":"99","author":"CA Pacak","year":"2006","unstructured":"Pacak CA, Mah CS, Thattaliyath BD, Conlon TJ, Lewis MA, Cloutier DE, Zolotukhin I, Tarantal AF, Byrne BJ (2006) Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res 99:e3\u2013e9. https:\/\/doi.org\/10.1161\/01.RES.0000237661.18885.f6","journal-title":"Circ Res"},{"key":"2521_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1479-0556-6-13","volume":"6","author":"CA Pacak","year":"2008","unstructured":"Pacak CA, Sakai Y, Thattaliyath BD, Mah CS, Byrne BJ (2008) Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice. Genet Vacc Ther 6:13. https:\/\/doi.org\/10.1186\/1479-0556-6-13","journal-title":"Genet Vacc Ther"},{"key":"2521_CR33","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/CIRCRESAHA.113.300269","volume":"113","author":"ST Pleger","year":"2013","unstructured":"Pleger ST, Brinks H, Ritterhoff J, Raake P, Koch WJ, Katus HA, Most P (2013) Heart failure gene therapy: the path to clinical practice. Circ Res 113:792\u2013809. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300269","journal-title":"Circ Res"},{"key":"2521_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"KM Prasad","year":"2011","unstructured":"Prasad KM, Xu Y, Yang Z, Acton ST, French BA (2011) Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther 18:43\u201352. https:\/\/doi.org\/10.1038\/gt.2010.105","journal-title":"Gene Ther"},{"key":"2521_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/humu.21599","volume":"33","author":"B Stallmeyer","year":"2012","unstructured":"Stallmeyer B, Zumhagen S, Denjoy I, Duthoit G, Hebert JL, Ferrer X, Maugenre S, Schmitz W, Kirchhefer U, Schulze-Bahr E, Guicheney P, Schulze-Bahr E (2012) Mutational spectrum in the Ca(2+)-activated cation channel gene TRPM4 in patients with cardiac conductance disturbances. Hum Mutat 33:109\u2013117. https:\/\/doi.org\/10.1002\/humu.21599","journal-title":"Hum Mutat"},{"key":"2521_CR36","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1161\/CIRCULATIONAHA.112.109256","volume":"126","author":"M Takefuji","year":"2012","unstructured":"Takefuji M, Wirth A, Lukasova M, Takefuji S, Boettger T, Braun T, Althoff T, Offermanns S, Wettschureck N (2012) G(13)-mediated signaling pathway is required for pressure overload-induced cardiac remodeling and heart failure. Circulation 126:1972\u20131982. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.109256","journal-title":"Circulation"},{"key":"2521_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.yjmcc.2014.06.007","volume":"74C","author":"S Uhl","year":"2014","unstructured":"Uhl S, Mathar I, Vennekens R, Freichel M (2014) Adenylyl cyclase-mediated effects contribute to increased Isoprenaline-induced cardiac contractility in TRPM4-deficient mice. J Mol Cell Cardiol 74C:307\u2013317. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.06.007","journal-title":"J Mol Cell Cardiol"},{"key":"2521_CR38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ni1441","volume":"8","author":"R Vennekens","year":"2007","unstructured":"Vennekens R, Olausson J, Meissner M, Bloch W, Mathar I, Philipp SE, Schmitz F, Weissgerber P, Nilius B, Flockerzi V, Freichel M (2007) Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat Immunol 8:312\u2013320. https:\/\/doi.org\/10.1038\/ni1441","journal-title":"Nat Immunol"},{"key":"2521_CR39","doi-asserted-by":"publisher","first-page":"20850","DOI":"10.1073\/pnas.0710565105","volume":"104","author":"J Wang","year":"2007","unstructured":"Wang J, Theunissen TW, Orkin SH (2007) Site-directed, virus-free, and inducible RNAi in embryonic stem cells. Proc Natl Acad Sci U S A 104:20850\u201320855. https:\/\/doi.org\/10.1073\/pnas.0710565105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2521_CR40","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.4049\/jimmunol.1000880","volume":"185","author":"KS Weber","year":"2010","unstructured":"Weber KS, Hildner K, Murphy KM, Allen PM (2010) Trpm4 differentially regulates Th1 and Th2 function by altering calcium signaling and NFAT localization. J Immunol 185:2836\u20132846. https:\/\/doi.org\/10.4049\/jimmunol.1000880","journal-title":"J Immunol"},{"key":"2521_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cvr\/cvu174","volume":"104","author":"S Werfel","year":"2014","unstructured":"Werfel S, Jungmann A, Lehmann L, Ksienzyk J, Bekeredjian R, Kaya Z, Leuchs B, Nordheim A, Backs J, Engelhardt S, Katus HA, Muller OJ (2014) Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase. Cardiovasc Res 104:15\u201323. https:\/\/doi.org\/10.1093\/cvr\/cvu174","journal-title":"Cardiovasc Res"},{"key":"2521_CR42","doi-asserted-by":"publisher","first-page":"eaay6812","DOI":"10.1126\/sciadv.aay6812","volume":"6","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li H, Min YL, Sanchez-Ortiz E, Huang J, Mireault AA, Shelton JM, Kim J, Mammen PPA, Bassel-Duby R, Olson EN (2020) Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system. Sci Adv 6:eaay6812. https:\/\/doi.org\/10.1126\/sciadv.aay6812","journal-title":"Sci Adv"},{"key":"2521_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1752-8062.2010.00190.x","volume":"3","author":"C Zincarelli","year":"2010","unstructured":"Zincarelli C, Soltys S, Rengo G, Koch WJ, Rabinowitz JE (2010) Comparative cardiac gene delivery of adeno-associated virus serotypes 1-9 reveals that AAV6 mediates the most efficient transduction in mouse heart. Clin Transl Sci 3:81\u201389. https:\/\/doi.org\/10.1111\/j.1752-8062.2010.00190.x","journal-title":"Clin Transl Sci"},{"key":"2521_CR44","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","volume":"6","author":"S Zolotukhin","year":"1999","unstructured":"Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6:973\u2013985. https:\/\/doi.org\/10.1038\/sj.gt.3300938","journal-title":"Gene Ther"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-021-02521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-021-02521-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-021-02521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T13:17:26Z","timestamp":1615209446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-021-02521-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1007\/s00424-021-02521-6","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"30 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patrick Most, Martin Busch, and Dirk Grimm are co-founders and shareholders of the company AaviGen GmbH. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}